"Sinoful Medical" completed a Series B+ financing of 128 million yuan.

36Kr exclusively learned that Sinovo Biomedical, an enterprise in the field of precision medicine, has recently completed a Series B+ financing round of 128 million yuan. This round of financing is led by HM Capital, with Kai Feng Venture Capital and Nanwan Bai'ao as co-investors. The raised funds will be mainly used for the marketing promotion of digital PCR products, the development of related reagent product lines, and the large-scale expansion of overseas markets.